aod9604 human clinical trials efficacy weight loss side effects AOD 9604: The Complete Evidence-Based Guide to the F Does AOD9604 peptide demonstrate effective

Reduction of Abdominal and Visceral Fat : Animal and early human models have demonstrated a preferential reduction of abdominal fat following subcutaneous administration of AOD-9604

It stimulates lipolysis (breakdown of stored fats) and inhibits lipogenesis (formation of new fat), primarily via activation of -adrenergic and AMP-activated protein kinase (AMPK) pathways

Capsules should be taken with water, and spacing doses throughout the day helps maintain steady levels in the bloodstream

doi: 10.1146/annurev-cellbio-100814-125544

Also, although there was a trend toward lower muscle cell fats when combining the NNMT-inhibiting compound with exercise, the decline was not significant